(Q53244764)

12 May 2018

title

Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma. (English)

1 reference

12 May 2018

author name string

A H Meyer

1

1 reference

12 May 2018

A Stroux

2

1 reference

12 May 2018

K Lerch

3

1 reference

12 May 2018

J Eucker

4

1 reference

12 May 2018

J Eitle

5

1 reference

12 May 2018

K Hohloch

6

1 reference

12 May 2018

M Andrzejak

7

1 reference

12 May 2018

K Possinger

8

1 reference

12 May 2018

B Dörken

9

1 reference

12 May 2018

A Pezzutto

10

1 reference

12 May 2018

C W Scholz

11

1 reference

12 May 2018

publication date

1 January 2014

1 reference

12 May 2018

published in

Annals of Oncology

1 reference

12 May 2018

volume

25

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

210-215

1 reference

12 May 2018

Management of marginal zone lymphomas

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT507

Treatment of elderly patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT507

Review of survival analyses published in cancer journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT507

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT507

Marginal zone lymphomas: factors that affect the final outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT507

Patterns of survival of follicular lymphomas at a single institution through three decades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT507

Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT507

Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT507

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT507

Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT507

Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Stu

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT507

Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT507

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDT507

1 reference

12 May 2018

1 reference

12 May 2018